External guide sequence technology: a path to development of novel antimicrobial therapeutics

Carol Davies-Sala1,2, Alfonso Soler-Bistué1,2, Robert A Bonomo3

  • 1Fundación Instituto Leloir, IIBBA-CONICET, and FCEyN, University of Buenos Aires, Argentina.

Summary

External guide sequences (EGS) leverage RNase P ribozyme activity to cleave target messenger RNAs (mRNAs), inhibiting gene expression. This technology shows promise for developing new treatments for infections and diseases.